Pilot trials with long-acting pipotiazine injections.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002389:Catatonia / Q000188:drug therapy; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010169:Palmitic Acids / Q000008:administration & dosage* / Q000009:adverse effects*; D010865:Pilot Projects; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D012562:Schizophrenia, Disorganized / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced
D014150:Antipsychotic Agents; D010169:Palmitic Acids; D010880:Piperidines; D013449:Sulfonamides; D008728:Methotrimeprazine; D002746:Chlorpromazine